Modified GRF (1-29) Peptide 2mg Vial – GHRH Research Peptide

What Is Modified GRF (1-29)?

Modified GRF (1-29), also known as a refined GHRH analog, is a synthetic peptide widely used in growth hormone research. Designed for improved stability, it mimics natural growth hormone-releasing hormone while offering more consistent performance in laboratory settings.

Número CAS	863288-34-0
Outros Nomes	Modified GRF (1-29), Tetrasubstituted GRF (1-29),
Nome IUPAC	N/D
Fórmula Molecular	C₁₅₂H₂₅₂N₄₄O₄₂
Peso Molecular	3367.95
Pureza	≥99% Puro (LC-MS)
Disponibilidade Líquida	N/D
Disponibilidade de Pó	2 milligrams (lyophilized/freeze-dried)
Condições de armazenamento	Conserve em local fresco, mantenha refrigerado. NÃO congele.
Termos	Todos os produtos destinam-se EXCLUSIVAMENTE a investigação e desenvolvimento laboratorial. Os produtos não se destinam ao consumo humano.

---

Como Funciona

Growth Hormone Signaling Support

This peptide binds to GHRH receptors in the pituitary gland, helping researchers study pulsatile growth hormone release—a key factor in understanding endocrine balance and metabolic processes.

---

Why Choose a 2mg Vial?

Precision & Flexibility

The 2mg lyophilized format allows:

• Accurate measurement

• Controlled dosing in experiments

• Reliable storage and handling

Researchers often value its predictable response and stability, making it a dependable tool in peptide studies.

---

Storage Guidelines

• Store in a cool, dry place

• Refrigerate at 2–8°C after reconstitution

• Avoid repeated freeze–thaw cycles

---

Perguntas Frequentes

What is Modified GRF (1-29) used for?

It is used in research involving growth hormone release and endocrine signaling.

How is it different from CJC-1295 with DAC?

It has a shorter action, allowing more natural hormone release patterns.

Is it for human use?

No, it is strictly for laboratory research purposes only.